253 related articles for article (PubMed ID: 16687222)
1. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
Orlu M; Cevher E; Araman A
Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of eudragit RS 100 loaded microsponges and its colonic delivery using natural polysaccharides.
Jain V; Singh R
Acta Pol Pharm; 2010; 67(4):407-15. PubMed ID: 20635537
[TBL] [Abstract][Full Text] [Related]
3. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
Jain V; Singh R
Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the morphology of benzoyl peroxide microsponges.
Nokhodchi A; Jelvehgari M; Siahi MR; Mozafari MR
Micron; 2007; 38(8):834-40. PubMed ID: 17692528
[TBL] [Abstract][Full Text] [Related]
5. The effects of pressure and direct compression on tabletting of microsponges.
Comoglu T; Gönül N; Baykara T
Int J Pharm; 2002 Aug; 242(1-2):191-5. PubMed ID: 12176245
[TBL] [Abstract][Full Text] [Related]
6. Factors effecting the morphology of Eudragit S-100 based microsponges bearing dicyclomine for colonic delivery.
Jain V; Jain D; Singh R
J Pharm Sci; 2011 Apr; 100(4):1545-52. PubMed ID: 20960455
[TBL] [Abstract][Full Text] [Related]
7. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium.
Maiti S; Kaity S; Ray S; Sa B
Acta Pharm; 2011 Sep; 61(3):257-70. PubMed ID: 21945905
[TBL] [Abstract][Full Text] [Related]
9. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet.
Srivastava R; Kumar D; Pathak K
Int J Pharm; 2012 May; 427(2):153-62. PubMed ID: 22306039
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
11. Development and optimization of flurbiprofen loaded microsponges; an in-vitro evaluation.
Qureshi S; Zaman M; Mahmood A; Shah S; Amjad MW; Shaheryar ZA; Sarfraz RM; Khan SM; Raja MAG
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1773-1779. PubMed ID: 31680072
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
[TBL] [Abstract][Full Text] [Related]
14. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
Choudhury PK; Ranawat MS; Pillai MK; Chauhan CS
Acta Pharm; 2007 Sep; 57(3):343-50. PubMed ID: 17878113
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
Mathew ST; Devi SG; KV S
AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
[TBL] [Abstract][Full Text] [Related]
17. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
18. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
Devrim B; Canefe K
Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
